Agentur Farner
Edit

Agentur Farner

https://www.farner.ch/
Last activity: 26.06.2022
Active
Categories: AdTechAgencyBrandCorporateGrowthManagementMediaMessangerPublicReputation
Farner Consulting entwickelt, konzipiert und realisiert integrierte Kommunikation mit 140 Mitarbeitern in über 20 spezialisierten Branchen-Teams in Zürich, Bern, St. Gallen, Genf, Lausanne, Lugano und Basel.

1951 als «Pressebüro Dr. Rudolf Farner» gegründet, etabliert sich die erste PR-Agentur der Schweiz über ihre Pionierarbeit in Public Relations, Public Affairs, Campaigning und Corporate Communications bald als führendes Unternehmen der noch jungen Branche.

Heute stehen wir für einen vollständig integrierten Ansatz in der Beratung und Umsetzung und betreiben neben PR und Corporate Communications auch Units für Digital Marketing, Change und Brand Communications und eine Full-Service-Werbeagentur.

Neben 2012 wurden wir 2015 zum zweiten Mal zum Beratungsunternehmen des Jahres in der Region Deutschland, Österreich und Schweiz gekürt («The Holmes Report»). Seit vielen Jahren führen wir das nationale BPRA-Ranking an, des Bundes der Public-Relations-Agenturen der Schweiz.

Wir sind Exclusive Affiliate von FleishmanHillard in der Schweiz. FleishmanHillard zählt zu den weltweit grössten PR-Agenturen und ist in allen wichtigen Märkten an über 80 Standorten tätig. Zudem sind wir Vertreter von Regester Larkin, dem weltweiten Branchenleader für Krisenkommunikation und Krisenmanagement.

Seit 2016 sind wir Partner des Reputation Institute. Das 1997 gegründete Institut ist ein internationales Expertennetzwerk auf dem Gebiet der Reputationsforschung und verfügt über eine weltweit einzigartige Datenbank zur Reputation von über 7000 Unternehmen.

E-Mail: info@farner.ch
Telefon: +41 44 266 67 67
www.farner.ch
Likes
959
Followers
1.74K
Followers
6.24K
Website visits
6.5K /mo.
Mentions
18
Location: Switzerland, Zurich
Employees: 51-200
Phone: +41 44 266 67 67
Founded date: 1951

Investors 2

DateNameWebsite
26.06.2022Waterland ...waterland....
23.06.2022Waterland ...waterland....

Mentions in press and media 18

DateTitleDescription
14.02.2022Achiko AG Research Paper and Commercialisation UpdateEQS-Ad-hoc: Achiko AG / Key word(s): Research Update Achiko AG Research Paper and Commercialisation Update 14-Feb-2022 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the conten...
27.01.2022Achiko AG strengthens senior team with appointment of Head of Corporate DevelopmentEQS-Ad-hoc: Achiko AG / Key word(s): Personnel Achiko AG strengthens senior team with appointment of Head of Corporate Development 27-Jan-2022 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely re...
17.01.2022Achiko AG Announces Feature Article on How We Get Back to Normal with its AptameXTM Covid-19 Rapid Test TechnologyEQS-News: Achiko AG / Key word(s): Miscellaneous Achiko AG Announces Feature Article on How We Get Back to Normal with its AptameXTM Covid-19 Rapid Test Technology 17.01.2022 / 14:08 Achiko AG Announces Feature Article on How We Get Back to...
14.01.2022Achiko AG Reports Breakthrough Calibration Results for AptameX Covid-19 Rapid Test TechnologyEQS-Ad-hoc: Achiko AG / Key word(s): Research Update Achiko AG Reports Breakthrough Calibration Results for AptameX Covid-19 Rapid Test Technology 14-Jan-2022 / 07:31 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The iss...
23.12.2021Achiko AG looks back at pivotal year and reaffirms commitment to provide affordable and accurate Covid-19 testing solutionEQS-News: Achiko AG / Key word(s): Miscellaneous Achiko AG looks back at pivotal year and reaffirms commitment to provide affordable and accurate Covid-19 testing solution 23.12.2021 / 06:45 Achiko AG looks back at pivotal year and reaffirm...
14.12.2021Achiko completes share capital increaseEQS-Ad-hoc: Achiko AG / Key word(s): Miscellaneous Achiko completes share capital increase 14-Dec-2021 / 18:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announ...
08.12.2021Achiko's Commercialisation Update: Optimised second-generation Covid-19 diagnostic test receives full product registration approval in IndonesiaEQS-Ad-hoc: Achiko AG / Key word(s): Miscellaneous Achiko's Commercialisation Update: Optimised second-generation Covid-19 diagnostic test receives full product registration approval in Indonesia 08-Dec-2021 / 06:45 CET/CEST Release of an a...
29.11.2021Code Pharma BV: COVID-19 drug developer Code Pharma announces limited fundraising round for international professional investors and plans for IPOEQS Group-News: Code Pharma BV / Key word(s): Investment Code Pharma BV: COVID-19 drug developer Code Pharma announces limited fundraising round for international professional investors and plans for IPO 29.11.2021 / 13:53 PRESS RELEASE COV...
24.11.2021Achiko's Covid-19 DNA aptamer-based rapid testing platform updateEQS Group-Ad-hoc: Achiko AG / Key word(s): Miscellaneous Achiko's Covid-19 DNA aptamer-based rapid testing platform update 24-Nov-2021 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsibl...
27.09.2021Achiko : reports first half to 30 June 2021 results and provides corporate updateEQS Group-Ad-hoc: Achiko AG / Key word(s): Half Year Results Achiko AG reports first half to 30 June 2021 results and provides corporate update 27-Sep-2021 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In